Local soft-tissue sarcoma recurrence: what happens next
Recurrence does not automatically mean loss of the limb or absence of treatment options. The extent of disease and resectability must be assessed again.
Why this case matters
This case shows a local recurrence of a grade 2 liposarcoma in the thigh. After repeat assessment and planning, a wide excision was performed. A recurrence is not treated by mechanically repeating the first operation: anatomy, scars, previous margins and reconstructive options all need a fresh review.


What needs to be reassessed
- local extent on a current MRI;
- presence or absence of distant disease;
- previous operative fields and radiotherapy;
- whether oncologically appropriate margins are achievable;
- the need for plastic, vascular or orthopaedic reconstruction.
Key point: local recurrence requires restaging, reassessment of resectability and treatment planning at an experienced sarcoma centre.
Clinical materials from the author’s archive are published with confirmed consent. Images are de-identified and are intended for education, not individual medical advice.
Related resources
What to read next
The decision should stay inside one pathway
Local recurrence requires a fresh assessment of anatomy, previous margins, radiotherapy, repeat resection and reconstruction. In a specialized sarcoma treatment unit, recurrence is treated as a new MDT problem rather than simply another operation.
GEIS 2018 and NETSARC 2019 linked reference-center sarcoma care with better oncological outcomes; in NETSARC, surgery in a reference center was independently associated with better overall survival (HR 0.681). These are observational data. GEIS · NETSARC.